
### [MONDO:0009499](http://purl.obolibrary.org/obo/MONDO_0009499)
**Label:** Krabbe disease

**Subclasses:** [MONDO:0016090](http://purl.obolibrary.org/obo/MONDO_0016090) (late-infantile/juvenile Krabbe disease), [MONDO:0016089](http://purl.obolibrary.org/obo/MONDO_0016089) (infantile Krabbe disease), [MONDO:0012720](http://purl.obolibrary.org/obo/MONDO_0012720) (Krabbe disease, atypical, due to saposin a deficiency), [MONDO:0016091](http://purl.obolibrary.org/obo/MONDO_0016091) (adult Krabbe disease), 

**Mapped go classes:** [GO:0007193](http://purl.obolibrary.org/obo/GO_0007193) (adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway), [GO:0043408](http://purl.obolibrary.org/obo/GO_0043408) (regulation of MAPK cascade), [GO:1903206](http://purl.obolibrary.org/obo/GO_1903206) (negative regulation of hydrogen peroxide-induced cell death), [GO:0008047](http://purl.obolibrary.org/obo/GO_0008047) (enzyme activator activity), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0060742](http://purl.obolibrary.org/obo/GO_0060742) (epithelial cell differentiation involved in prostate gland development), [GO:0004565](http://purl.obolibrary.org/obo/GO_0004565) (beta-galactosidase activity), [GO:0006665](http://purl.obolibrary.org/obo/GO_0006665) (sphingolipid metabolic process), [GO:0001664](http://purl.obolibrary.org/obo/GO_0001664) (G-protein coupled receptor binding), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0071310](http://purl.obolibrary.org/obo/GO_0071310) (cellular response to organic substance), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:1905574](http://purl.obolibrary.org/obo/GO_1905574) (ganglioside GM2 binding), [GO:1905573](http://purl.obolibrary.org/obo/GO_1905573) (ganglioside GM1 binding), [GO:1905572](http://purl.obolibrary.org/obo/GO_1905572) (ganglioside GM1 transport to membrane), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:1905577](http://purl.obolibrary.org/obo/GO_1905577) (ganglioside GP1c binding), [GO:1905576](http://purl.obolibrary.org/obo/GO_1905576) (ganglioside GT1b binding), [GO:1905575](http://purl.obolibrary.org/obo/GO_1905575) (ganglioside GM3 binding), [GO:0060736](http://purl.obolibrary.org/obo/GO_0060736) (prostate gland growth), [GO:0043410](http://purl.obolibrary.org/obo/GO_0043410) (positive regulation of MAPK cascade), [GO:0048589](http://purl.obolibrary.org/obo/GO_0048589) (developmental growth), [GO:0005543](http://purl.obolibrary.org/obo/GO_0005543) (phospholipid binding), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0019216](http://purl.obolibrary.org/obo/GO_0019216) (regulation of lipid metabolic process), 

**Class expressions from DL-Learner:**

- [GO:0097001](http://purl.obolibrary.org/obo/GO_0097001) (ceramide binding) 75.00%
- [GO:0051861](http://purl.obolibrary.org/obo/GO_0051861) (glycolipid binding) 75.00%
- [GO:0046625](http://purl.obolibrary.org/obo/GO_0046625) (sphingolipid binding) 75.00%
- [GO:0043208](http://purl.obolibrary.org/obo/GO_0043208) (glycosphingolipid binding) 75.00%
- [GO:0035594](http://purl.obolibrary.org/obo/GO_0035594) (ganglioside binding) 75.00%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0097001](http://purl.obolibrary.org/obo/GO_0097001) (ceramide binding) 75.00%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0051861](http://purl.obolibrary.org/obo/GO_0051861) (glycolipid binding) 75.00%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0046625](http://purl.obolibrary.org/obo/GO_0046625) (sphingolipid binding) 75.00%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0043208](http://purl.obolibrary.org/obo/GO_0043208) (glycosphingolipid binding) 75.00%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0035594](http://purl.obolibrary.org/obo/GO_0035594) (ganglioside binding) 75.00%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0097001](http://purl.obolibrary.org/obo/GO_0097001) (ceramide binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 75.00%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0051861](http://purl.obolibrary.org/obo/GO_0051861) (glycolipid binding) and [GO:0097001](http://purl.obolibrary.org/obo/GO_0097001) (ceramide binding) 75.00%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0046625](http://purl.obolibrary.org/obo/GO_0046625) (sphingolipid binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 75.00%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0046625](http://purl.obolibrary.org/obo/GO_0046625) (sphingolipid binding) and [GO:0051861](http://purl.obolibrary.org/obo/GO_0051861) (glycolipid binding) 75.00%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0043208](http://purl.obolibrary.org/obo/GO_0043208) (glycosphingolipid binding) and [GO:0097001](http://purl.obolibrary.org/obo/GO_0097001) (ceramide binding) 75.00%


